In vivo, the E-selectin targeted polymer-drug conjugates (P-Esbp-DOX and P-Esbp-KLAK) decreased the rate of tumor growth and prolonged the survival of mice bearing primary Lewis lung carcinoma, or established melanoma (B16-F10) lung metastases (86). Here, SELE is linked to neoplasm.